Barclays »

Bright Minds Biosciences shares owned by Barclays

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $399k 6.6k 60.66
2025-06-30 $219k 8.4k 26.09

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
Vivo Capital
Commodore Capital
Perceptive Advisors
Adage Capital Partners GP
Braidwell
BlackRock
Sio Capital Management
Balyasny Asset Management
Morgan Stanley
Point72 Asset Management
Longwood Capital Partners
Millennium Management
Walleye Trading Advisors

View all funds holding Bright Minds Biosciences